Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations

Takeaway

  • Neurocognitive degeneration in patients with retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) may occur as a result of white matter atrophy which degenerates in a linear manner, providing a possible metric to measure therapeutic efficacy.

Why this matters

  • RVCL-S is a genetic disease that leads to loss of vision and neurocognitive degeneration. Characterizing the disease progression of RVCL-S has proved difficult due to the rare nature of this disease; due to this, the therapeutic efficacy of potential treatments has been difficult to evaluate. Therefore, it is important to characterize the natural history of RVCL-S in order to evaluate the efficacy of future therapies.

続きを読む

ログインまたは新規会員登録するとneurodiemのすべてのコンテンツにアクセスできます。

会員登録がお済みの方はこちら ログイン

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.